Baxter International Inc., BAX is in the exchange NYSE and its industry is Medical Instruments & Supplies in the sector of Healthcare. Based in USA, Baxter International Inc., BAX has a market cap of 25245.91. Since its IPO date on the 10/27/1981, Baxter International Inc., BAX performance year to date is 20.12%. Today Baxter International Inc., BAX has gained 0.33%, with a current price of 45.58.
Ownership of the company is 0.10% for insider ownership while institutional ownership is 87.50%. The management of the company have seen the company have a payout ratio of 5.40%. Return of assets are at 25.80%, with return on investment at 3.40%.
In terms of debt levels and profit levels, Baxter International Inc., BAX is seeing a long-term debt/equity of 0.25. While Total debt/equity is 0.37. With a profit margin of 47.70%, this is combined with a gross margin of 39.00%, and operating margin of -13.50%. Baxter International Inc. ability to meet debt levels, with a current ratio of 1.8, while the quick ratio is 1.4.
For the last year Baxter International Inc., BAX has seen a EPS growth of -79.90%. A performance for the year of 26.80%. The 52-week high is -7.64%, and the 52-week low is 43.31%. The average volume for Baxter International Inc., BAX is 122561.
With a target price of 50.25, can Baxter International Inc., BAX reach this target? Looking at the value indicators of Baxter International Inc., BAX. Baxter International Inc. has a P/E of 5.24 and a forward P/E of 23.07. Perhaps the more useful indicator than P/E, is PEG which has a value of 0.42. Baxter International Inc. also has a P/S and a P/B of 2.51 and 2.93 respectively. For P/cash, Baxter International Inc. has a value of 9.6, while it is 32.41 for P/free cash flow.
At the current price of 45.58, Baxter International Inc. has a dividend yield of 1.14%. We see a return on equity of 56.10%.
Looking more long-term Baxter International Inc., is projected to get an EPS growth for the next five years of 12.63%. In the short-term an EPS growth of 14.21% in the next year is forecasted. This is after a EPS growth of -79.90% for this year and for the last five years a -21.40% growth has been seen.